Your browser doesn't support javascript.
loading
The FDA-approved drug sofosbuvir inhibits Zika virus infection.
Bullard-Feibelman, Kristen M; Govero, Jennifer; Zhu, Zhe; Salazar, Vanessa; Veselinovic, Milena; Diamond, Michael S; Geiss, Brian J.
Afiliação
  • Bullard-Feibelman KM; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
  • Govero J; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Zhu Z; Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Salazar V; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Veselinovic M; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
  • Diamond MS; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO, USA; Department of Molecular Microbiology, Washington University School of Medicine, Saint Louis, MO, USA; The Ce
  • Geiss BJ; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA; School of Biomedical Engineering, Colorado State University, Fort Collins, CO, USA. Electronic address: brian.geiss@colostate.edu.
Antiviral Res ; 137: 134-140, 2017 01.
Article em En | MEDLINE | ID: mdl-27902933

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Sofosbuvir / Zika virus / Infecção por Zika virus Limite: Animals / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Sofosbuvir / Zika virus / Infecção por Zika virus Limite: Animals / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2017 Tipo de documento: Article